
America’s obesity crisis meets the Ozempic boom as data reveals GLP-1 hot spots
Fox News
Southern and Midwest states show highest GLP-1 prescription rates for weight-loss drugs, correlating with obesity patterns as President Donald Trump promises lower prices.
Melissa Rudy is senior health editor and a member of the lifestyle team at Fox News Digital. Story tips can be sent to melissa.rudy@fox.com.
The prescription records came from both commercial and government insurers, and they don’t include people who paid cash, used telehealth providers, used compounded versions or were uninsured — which means the actual numbers are likely higher.
More Related News













